- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Mochida Pharmaceutical (4534)
Track today's live Mochida Pharmaceutical (4534) share price, performance and key data on this page with our current Tokyo:4534 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Mochida Pharmaceutical share price on the Tokyo exchange. Use the dropdown to switch exchange for the 4534 share price, head to our technical summary section, which provides analysis on Mochida Pharmaceutical share price buy/sell indicators using real-time data (or discuss the Mochida Pharmaceutical (4534) stock price today with other investors in the Mochida Pharmaceutical TYO share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TYO:4534 share price (ISIN: JP3922800002) to enhance your trading decisions with our free investment tools and resources.
What Is the Mochida Pharmaceutical Share Price Today?
The Mochida Pharmaceutical share price today is 3,135.0.
What Is the Stock Symbol for Mochida Pharmaceutical
The stock symbol (or 'ticker') for Mochida Pharmaceutical is "4534."
What Stock Exchange Does Mochida Pharmaceutical Trade On?
Mochida Pharmaceutical is listed and trades on the Tokyo stock exchange.
Is Mochida Pharmaceutical a Good Stock to Buy?
Determining whether Mochida Pharmaceutical (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current TYO:4534 share price (ISIN: JP3922800002) to enhance your trading decisions with our free investment tools and resources.
What Is the Mochida Pharmaceutical Share Price Today?
The Mochida Pharmaceutical share price today is 3,135.0.
What Is the Stock Symbol for Mochida Pharmaceutical
The stock symbol (or 'ticker') for Mochida Pharmaceutical is "4534."
What Stock Exchange Does Mochida Pharmaceutical Trade On?
Mochida Pharmaceutical is listed and trades on the Tokyo stock exchange.
Is Mochida Pharmaceutical a Good Stock to Buy?
Determining whether Mochida Pharmaceutical (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Tokyo
Currency in JPY
3,135.0
+5.0(+0.16%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,130.0
3,160.0
52 wk Range
2,902.0
3,965.0
4534 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,130.03,160.0
52 wk Range
2,902.03,965.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.55%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.55%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4534 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
15/05/2026
EPS / Forecast
44.05 / --
Revenue / Forecast
29.46B / --
Compare 4534 to Peers and Sector
Metrics to compare | 4534 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4534PeersSector | |
|---|---|---|---|---|
P/E Ratio | 14.1x | 16.6x | −0.4x | |
PEG Ratio | 0.36 | −0.13 | 0.00 | |
Price/Book | 0.8x | 0.9x | 2.6x | |
Price / LTM Sales | 1.0x | 1.1x | 3.0x | |
Upside (Analyst Target) | - | 18.7% | 51.9% | |
Fair Value Upside | Unlock | 13.0% | 9.1% | Unlock |
Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Epadel for hyperlidemia and arteriosclerosis obliterans; Urece for gout and hyperuricemia; Treprost for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; Atelec, a calcium channel blocker; Dinagest, an agent for endometriosis, adenomyosis, and dysmenorrhea; Lexapro, an antidepressant; Tamcet, an analgesic for chronic pain; Beselna, a therapeutic agent for condyloma acuminatum and actinic keratosis; and Heparin Sodium MOCHIDA anticoagulant agents. The company also develops mesalazine for the treatment of ulcerative colitis; tocilizumab for the treatment of rheumatoid arthritis; dotinurad for the treatment of gout and hyperuricemia; dienogest formulation for dysmenorrhea; treprostinil for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and icosapent for hypertriglyceridemia. In addition, it develops medical devices, including dMD-001 that is used for the treatment of articular cartilage lesions; dMD-002, which is used for the treatment of cavernous nerve injury; and dMD-003 for post-operative adhesion. Further, the company engages in the development, production, distribution, sale, and marketing of skincare products. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Mochida Pharmaceutical (Tokyo: 4534) Share Price Today?
The Mochida Pharmaceutical stock price today is 3,135.0 JPY.
What Stock Exchange Does Mochida Pharmaceutical (4534) Trade On?
Mochida Pharmaceutical is listed and trades on the Tokyo Stock Exchange.
What Is the Ticker (Stock Symbol) for Mochida Pharmaceutical?
The stock symbol (also called a 'ticker') for Mochida Pharmaceutical is "4534."
Does Mochida Pharmaceutical Pay Dividends? What’s The Current 4534 Dividend Yield?
Yes, 4534 Pays Dividends to its Shareholders. The current Mochida Pharmaceutical dividend yield is 2.55%.
What Is the Current Mochida Pharmaceutical Market Capitalisation?
As of today, Mochida Pharmaceutical (Tokyo: 4534) market cap is 111.13B JPY.
What Is Mochida Pharmaceutical's (4534) Earnings Per Share (TTM)?
The Mochida Pharmaceutical EPS is currently 222.9 (Trailing Twelve Months).
When Is the Next Mochida Pharmaceutical Earnings Date?
Mochida Pharmaceutical's next earnings report will be released on 03/08/2026.
Is 4534 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Mochida Pharmaceutical moving averages and other technical indicators, the daily buy/sell signal for 4534 stock is Strong Sell.
How Many Times Has Mochida Pharmaceutical Stock Split?
Mochida Pharmaceutical has split 4 times. (See the 4534 stock split history page for full effective split date and price information.)
How Many Employees Does Mochida Pharmaceutical Have?
Mochida Pharmaceutical has 1479 employees, based on their latest Companies House report.
What is the current trading status of Mochida Pharmaceutical (Tokyo: 4534)?
As of 10/07/2026, Mochida Pharmaceutical (4534) is trading at a share price of 3,135.0 JPY, with a previous close of 3,130.0 JPY. The stock has fluctuated within a day range of 3,130.0 JPY to 3,160.0 JPY, while its 52-week range spans from 2,902.0 JPY to 3,965.0 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.